Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 2Lymphoid 1

Conditions

Anemia, Refractory, with Excess of Blasts 271Leukemia, Myeloid, Acute 258Myelodysplastic Syndromes 254Anemia 245Leukemia 228Neoplasms 211Precursor Cell Lymphoblastic Leukemia-Lymphoma 182Leukemia, Myelomonocytic, Chronic 151Multiple Myeloma 138Venous Thromboembolism 137Myeloproliferative Disorders 131Leukemia, Lymphocytic, Chronic, B-Cell 126Lymphoma 119Lymphoma, Non-Hodgkin 118Thrombocytopenia 117Hodgkin Disease 103Anemia, Aplastic 97Febrile Neutropenia 86Hematologic Neoplasms 82Anemia, Refractory 82Primary Myelofibrosis 81Lymphoma, Follicular 81Congenital Abnormalities 81Leukemia, Myeloid, Chronic-Phase 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 73Blast Crisis 72Leukemia, Myeloid, Accelerated Phase 69Lymphoma, Mantle-Cell 68Neoplasms, Plasma Cell 66Myelodysplastic-Myeloproliferative Diseases 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Shock, Septic × Classical hematology × Clear all
NCT07277387 2026-04-23

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Instituto de Investigación Biomédica de Salamanca

Not yet recruiting
350 enrolled
Classical hematologyOther hematologic neoplasm

Shock, Septic, Sepsis, Hematologic Neoplasms, Febrile Neutropenia

NCT03837171 2024-06-25

TRANSPORT

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
192 enrolled
Classical hematology

Anemia, Neoplasms, Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡